bezafibrate has been researched along with Hyperlipoproteinemia in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (65.00) | 18.7374 |
| 1990's | 10 (25.00) | 18.2507 |
| 2000's | 4 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gozzo, E; Gurrera, A; Ignaccolo, L; Magro, G; Neri, S; Scavo, S | 1 |
| Fujioka, D; Ichigi, Y; Kawabata, K; Kitta, Y; Kodama, Y; Kugiyama, K; Mende, A; Nakamura, T; Obata, JE; Saito, Y; Takano, H; Umetani, K | 1 |
| Nosaka, S; Sakuma, K; Ushiroyama, T | 1 |
| Vinazzer, H | 1 |
| Bartosiewicz, W; Ilińska-Debniak, K; Stryjek-Kamińska, D; Szczepanik, Z | 1 |
| Leiss, O; von Bergmann, K | 1 |
| Apostolova, Iu; Kiriakov, A; Malamov, E; Tinterova, Z; Tsenov, I | 1 |
| Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG | 1 |
| Fischer, H; Oster, P; Roche, A; Schellenberg, B; Schlierf, G; Stiehl, A; Vollmar, J | 1 |
| Dorda, W; Kostner, GM; Mühlhauser, I; Prager, R; Schernthaner, G; Zechner, R | 1 |
| Djaja, S; Machalke, K; Richter, E | 1 |
| Lageder, H | 1 |
| Dick, TB; Ledermann, HM; Marples, J; Whittington, J | 1 |
| Bode, G; Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG | 1 |
| Lang, PD; Mertz, DP; Vollmar, J | 1 |
| Heidland, A; Hörl, M; Hörl, WH | 1 |
| Bruneder, H; Klein, HJ | 1 |
| Bachmann, C; Fragiacomo, C; Noseda, G; Weidmann, P | 1 |
| Homma, Y; Kobayashi, T; Mikami, Y; Nakamura, H; Ozawa, H; Sakane, H; Yamaguchi, H | 1 |
| Biasi, GM; Catapano, AL; Maggi, FM | 1 |
| Miyake, Y; Toyota, Y; Yamamoto, A; Yamamura, T | 1 |
| de Man, FH; Mohrschladt, MF; Smelt, AH; Stoeken, DJ; Sturk, A; Westendorp, RG; Weverling-Rijnsburger, AW | 1 |
| Soska, V | 1 |
| Holzgartner, H; Kuhn, U; Schmidt, U | 1 |
| Bergmann, S; Fücker, K; Gross, P; Hanefeld, M; Hora, C; Julius, U | 1 |
| Bradford, RH; Goldberg, AC; Knopp, RH; Schonfeld, G | 1 |
| Ditschuneit, HH; Ernst, E; Hehr, R; Hombach, V; Koenig, W; Kuhn, K; Rosenthal, J | 1 |
| Kłosiewicz-Latoszek, L; Szostak, WB | 1 |
| Ceska, R; Kvasilová, M; Procházková, P; Sobra, J | 1 |
| Saito, Y; Yoshida, S | 1 |
| Capaldo, B; Genovese, S; Mancini, M; Marotta, G; Patti, L; Postiglione, A; Riccardi, G; Rivellese, A; Saldalamacchia, G | 1 |
| Bonaiuto, M; Cinquegrani, M; Fodale, P; Lanzafame, F; Mazza, G; Micali, G; Mileto, A; Pangallo, A; Pernice, F; Saitta, A | 1 |
| Angelin, B; Eriksson, M | 1 |
| Lösch, W; Neugebauer, G; Platt, D; Vömel, T | 1 |
| Sermukslis, B; Smud, R | 1 |
| Postiglione, A; Riccardi, G; Saldalamacchia, G | 1 |
| Kłosiewicz-Latoszek, L; Naruszewicz, M; Nowicka, G; Szostak, WB | 1 |
| Berent, H; Kuczyńska, K; Młyński, J | 1 |
| Acuña, AM; Gladstein, J; Tesone, PA | 1 |
| Bachmann, C; Fragiacomo, C; Noseda, G; Schiffl, H; Weidmann, P | 1 |
1 review(s) available for bezafibrate and Hyperlipoproteinemia
| Article | Year |
|---|---|
[Present status of fibrates in the treatment of hyperlipoproteinemias].
Topics: Bezafibrate; Fenofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents | 1999 |
21 trial(s) available for bezafibrate and Hyperlipoproteinemia
| Article | Year |
|---|---|
Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Bezafibrate; Biomarkers; Cholesterol; Coronary Artery Disease; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Pyrroles; Risk Factors; Triglycerides; Vasodilation | 2005 |
Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women.
Topics: Bezafibrate; Cholesterol; Female; Humans; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, HDL; Middle Aged; Postmenopause | 2006 |
[Comparison of the antilipemic effect of bezafibrate with that of piperazine-sultosilate (A 585). A crossed double-blind study].
Topics: Adult; Aged; Alkaline Phosphatase; Bezafibrate; Cholesterol, HDL; Female; Fibrinolysis; gamma-Glutamyltransferase; Humans; Hyperlipoproteinemias; Lipoproteins, VLDL; Male; Middle Aged; Piperazines; Platelet Adhesiveness; Triglycerides | 1984 |
[Effect of bezafibrate on disorders of lipid metabolism].
Topics: Adult; Aged; Bezafibrate; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1983 |
Effect of short-term treatment with bezafibrate and fenofibrate on biliary lipid metabolism in patients with hyperlipoproteinaemia.
Topics: Bezafibrate; Bile; Cholesterol; Female; Fenofibrate; Gallbladder; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipid Metabolism; Male; Propionates; Triglycerides | 1984 |
[The effect of bezafibrate on biliary lipids (author's transl)].
Topics: Adult; Bezafibrate; Bile; Clofibrate; Clofibric Acid; Drug Evaluation; Humans; Hyperlipoproteinemias; Lipids | 1980 |
Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
Topics: Aged; Apolipoprotein A-II; Apolipoproteins; Apolipoproteins A; Apolipoproteins B; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Clofibric Acid; Diabetes Mellitus; Female; Humans; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Phosphatidylcholine-Sterol O-Acyltransferase | 1982 |
[Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate | 1982 |
[Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia].
Topics: Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemias; Male; Placebos; Triglycerides | 1980 |
Comparative study of once and 3-times daily regimens of bezafibrate in patients with primary hyperlipoproteinaemia.
Topics: Adult; Aged; Alkaline Phosphatase; Bezafibrate; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Creatinine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Urea | 1981 |
[Treatment of hyperlipoproteinaemia in diabetic patients (author's transl)].
Topics: Adult; Aged; Bezafibrate; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Diabetes Complications; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Phospholipids; Placebos; Triglycerides | 1981 |
Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Bezafibrate; Cross-Over Studies; Cytokines; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Reference Values | 2000 |
Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate.
Topics: Aged; Bezafibrate; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Garlic; Heart Rate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Male; Middle Aged; Odorants; Plants, Medicinal; Triglycerides | 1992 |
[Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia].
Topics: Adult; Aged; Bezafibrate; Cholesterol; Female; Gemfibrozil; Humans; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Triglycerides | 1992 |
Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia.
Topics: Adolescent; Adult; Aged; Bezafibrate; Double-Blind Method; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lipids; Lipoproteins; Male; Middle Aged | 1992 |
Lovastatin alters blood rheology in primary hyperlipoproteinemia: dependence on lipoprotein(a)?
Topics: Bezafibrate; Blood Viscosity; Delayed-Action Preparations; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Rheology; Single-Blind Method | 1992 |
Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes.
Topics: Adult; Bezafibrate; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipidemias; Hyperlipoproteinemias; Insulin; Insulin Secretion; Male; Middle Aged; Triglycerides | 1989 |
Bezafibrate and fenofibrate in type II diabetics with hyperlipoproteinaemia.
Topics: Adult; Bezafibrate; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fenofibrate; Humans; Hyperlipoproteinemias; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Propionates; Triglycerides | 1987 |
Hypolipidemic effects of bezafibrate: studies in Italy.
Topics: Bezafibrate; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Lipids; Lipoproteins; Random Allocation | 1986 |
Comparative study of bezafibrate and fenofibrate in patients with primary hyperlipoproteinaemia.
Topics: Adult; Bezafibrate; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Double-Blind Method; Female; Fenofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Propionates; Sex Factors; Triglycerides | 1985 |
[Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
Topics: Adult; Aged; Alkaline Phosphatase; Bezafibrate; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Creatine Kinase; Creatinine; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Long-Term Care; Male; Middle Aged; Placebos; Triglycerides | 1985 |
18 other study(ies) available for bezafibrate and Hyperlipoproteinemia
| Article | Year |
|---|---|
Isomorphic response in eruptive xanthomas.
Topics: Bezafibrate; Diagnosis, Differential; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Leg; Male; Middle Aged; Skin Diseases; Xanthomatosis | 2004 |
[Effect of 1 month's treatment with Bezalip on the serum lipids and lipoproteins of patients with different types of hyperlipoproteinemias].
Topics: Adult; Ambulatory Care; Bezafibrate; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Time Factors | 1983 |
Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
Topics: Aged; Bezafibrate; Female; Humans; Hyperlipoproteinemias; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged | 1983 |
[Bezafibrate in primary hyperlipidemias (author's transl)].
Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipidemias; Hyperlipoproteinemias; Lipoprotein Lipase; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged | 1982 |
Bezafibrate: lack of effect on creatinine excretion and muscular proteins.
Topics: Bezafibrate; Clofibrate; Clofibric Acid; Creatine Kinase; Creatinine; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Isoenzymes; Kidney; Male; Middle Aged; Muscle Proteins; Muscles; Myoglobinuria | 1982 |
[Fat and renal failure--therapeutic aspects].
Topics: Acute Kidney Injury; Animals; Bezafibrate; Carnitine; Charcoal; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Infusions, Parenteral; Kidney Failure, Chronic; Lipids; Physical Exertion; Rats; Renal Dialysis | 1982 |
[The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Topics: Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Lipoproteins, HDL; Triglycerides | 1980 |
Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
Topics: Adult; Aged; Bezafibrate; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Electrophoresis, Polyacrylamide Gel; Female; Glycoproteins; Humans; Hyperlipoproteinemias; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Triglycerides | 1994 |
Reduction of Lp(a) plasma levels by bezafibrate.
Topics: Bezafibrate; Humans; Hyperlipoproteinemias; Lipoprotein(a) | 1993 |
Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia.
Topics: Adult; Bezafibrate; Female; Humans; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Probucol; Receptors, LDL | 1999 |
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol | 1991 |
[Bezalip in the treatment of hyperlipoproteinemia].
Topics: Adult; Bezafibrate; Female; Humans; Hyperlipoproteinemias; Lipids; Male; Middle Aged | 1990 |
[Recent trend in the research of hyperlipidemia in Japan. Treatment of refractory hyperlipidemia].
Topics: Anticholesteremic Agents; Bezafibrate; Blood Component Removal; Cholesterol; Drug Therapy, Combination; Heptanoic Acids; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Naphthalenes; Pravastatin; Probucol; Triglycerides | 1989 |
[Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
Topics: Adult; Aged; Apolipoproteins A; Apolipoproteins B; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Evaluation; Female; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lipids; Male; Middle Aged; Time Factors; Triglycerides | 1988 |
Bezafibrate therapy and biliary lipids: effects of short-term and long-term treatment in patients with various forms of hyperlipoproteinaemia.
Topics: Adult; Aged; Bezafibrate; Bile; Cholesterol; Cholesterol, HDL; Diet; Female; Humans; Hyperlipoproteinemias; Lipid Metabolism; Lipids; Male; Middle Aged | 1987 |
Steady-state kinetics of bezafibrate retard in hyperlipidemic geriatric patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bezafibrate; Biological Availability; Delayed-Action Preparations; Female; Glomerular Filtration Rate; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Male; Metabolic Clearance Rate; Middle Aged; Triglycerides | 1988 |
Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
Topics: Adult; Aged; Apolipoproteins B; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Polyamines | 1987 |
[The effect of bezafibrate on the level of serum lipids, fatty acid lecithin-cholesterol transferase activity and certain parameters of the fibrinolytic system in patients with type IIb and type IV hyperlipoproteinemia].
Topics: Adult; Bezafibrate; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipoproteinemias; Lipids; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase | 1985 |